Cargando…
The outbreak of COVID-19: An overview
In late December 2019, a previous unidentified coronavirus, currently named as the 2019 novel coronavirus#, emerged from Wuhan, China, and resulted in a formidable outbreak in many cities in China and expanded globally, including Thailand, Republic of Korea, Japan, United States, Philippines, Viet N...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153464/ https://www.ncbi.nlm.nih.gov/pubmed/32134861 http://dx.doi.org/10.1097/JCMA.0000000000000270 |
_version_ | 1783521659463925760 |
---|---|
author | Wu, Yi-Chi Chen, Ching-Sung Chan, Yu-Jiun |
author_facet | Wu, Yi-Chi Chen, Ching-Sung Chan, Yu-Jiun |
author_sort | Wu, Yi-Chi |
collection | PubMed |
description | In late December 2019, a previous unidentified coronavirus, currently named as the 2019 novel coronavirus#, emerged from Wuhan, China, and resulted in a formidable outbreak in many cities in China and expanded globally, including Thailand, Republic of Korea, Japan, United States, Philippines, Viet Nam, and our country (as of 2/6/2020 at least 25 countries). The disease is officially named as Coronavirus Disease-2019 (COVID-19, by WHO on February 11, 2020). It is also named as Severe Pneumonia with Novel Pathogens on January 15, 2019 by the Taiwan CDC, the Ministry of Health and is a notifiable communicable disease of the fifth category. COVID-19 is a potential zoonotic disease with low to moderate (estimated 2%–5%) mortality rate. Person-to-person transmission may occur through droplet or contact transmission and if there is a lack of stringent infection control or if no proper personal protective equipment available, it may jeopardize the first-line healthcare workers. Currently, there is no definite treatment for COVID-19 although some drugs are under investigation. To promptly identify patients and prevent further spreading, physicians should be aware of the travel or contact history of the patient with compatible symptoms. |
format | Online Article Text |
id | pubmed-7153464 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-71534642020-04-15 The outbreak of COVID-19: An overview Wu, Yi-Chi Chen, Ching-Sung Chan, Yu-Jiun J Chin Med Assoc Review Articles In late December 2019, a previous unidentified coronavirus, currently named as the 2019 novel coronavirus#, emerged from Wuhan, China, and resulted in a formidable outbreak in many cities in China and expanded globally, including Thailand, Republic of Korea, Japan, United States, Philippines, Viet Nam, and our country (as of 2/6/2020 at least 25 countries). The disease is officially named as Coronavirus Disease-2019 (COVID-19, by WHO on February 11, 2020). It is also named as Severe Pneumonia with Novel Pathogens on January 15, 2019 by the Taiwan CDC, the Ministry of Health and is a notifiable communicable disease of the fifth category. COVID-19 is a potential zoonotic disease with low to moderate (estimated 2%–5%) mortality rate. Person-to-person transmission may occur through droplet or contact transmission and if there is a lack of stringent infection control or if no proper personal protective equipment available, it may jeopardize the first-line healthcare workers. Currently, there is no definite treatment for COVID-19 although some drugs are under investigation. To promptly identify patients and prevent further spreading, physicians should be aware of the travel or contact history of the patient with compatible symptoms. Wolters Kluwer Health 2020-03 2020-02-12 /pmc/articles/PMC7153464/ /pubmed/32134861 http://dx.doi.org/10.1097/JCMA.0000000000000270 Text en Copyright © 2020, the Chinese Medical Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | Review Articles Wu, Yi-Chi Chen, Ching-Sung Chan, Yu-Jiun The outbreak of COVID-19: An overview |
title | The outbreak of COVID-19: An overview |
title_full | The outbreak of COVID-19: An overview |
title_fullStr | The outbreak of COVID-19: An overview |
title_full_unstemmed | The outbreak of COVID-19: An overview |
title_short | The outbreak of COVID-19: An overview |
title_sort | outbreak of covid-19: an overview |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153464/ https://www.ncbi.nlm.nih.gov/pubmed/32134861 http://dx.doi.org/10.1097/JCMA.0000000000000270 |
work_keys_str_mv | AT wuyichi theoutbreakofcovid19anoverview AT chenchingsung theoutbreakofcovid19anoverview AT chanyujiun theoutbreakofcovid19anoverview AT wuyichi outbreakofcovid19anoverview AT chenchingsung outbreakofcovid19anoverview AT chanyujiun outbreakofcovid19anoverview |